De Witte Jan 4
4 · RESMED INC · Filed Nov 26, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
De Witte Jan
Director
Transactions
- Sale
ReMed Common Stock
2025-11-25$255.00/sh−2,055$524,025→ 4,261 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted on August 18, 2025.